EMFAT
BDTX icon

Emerald Mutual Fund Advisers Trust’s Black Diamond Therapeutics BDTX Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-107,060
Closed -$4.51M – 320
2020
Q2 		$4.51M Sell
107,060
-3,601
-3% -$133K 0.21% 114
2020
Q1 		$2.76M Buy
+110,661
New +$3.37M 0.17% 121

Other funds holding BDTX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's BDTX Position: Q3 2020 in Review

Emerald Mutual Fund Advisers Trust sold out of Black Diamond Therapeutics (BDTX) in Q3 2020, closing a stake of 107,060 shares — an estimated $4.51M sold.

Emerald Mutual Fund Advisers Trust first reported a position in BDTX in Q1 2020 and held it in 2 quarters. The position peaked at $4.51M in Q2 2020. 88 funds tracked by Wall St. Rank hold BDTX as of Q3 2020.

  • Emerald Mutual Fund Advisers Trust reported no remaining Black Diamond Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 107,060 Black Diamond Therapeutics shares in Q3 2020, an estimated $4.51M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Black Diamond Therapeutics in Q1 2020 and held it in 2 quarters.
  • Emerald Mutual Fund Advisers Trust's Black Diamond Therapeutics position peaked at $4.51M in Q2 2020.
  • 88 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q3 2020.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q3 2020, filed 28 Oct 2020.